もも_2828
reacted to
$Tesla (TSLA.US)$
I hope it returns to 450 by the end of the day.
I hope it returns to 450 by the end of the day.
Translated
13
$Tesla (TSLA.US)$ It became a recall, but the response was so quick that it actually gained favor?
Translated
6
もも_2828
reacted to
$Torm (TRMD.US)$ If the window is not opened for about 3 consecutive days, I still can't relax, but finally there are signs of bottoming out. I moved to MSTR and SMCI, thinking I would lose anyway.
Translated
14
もも_2828
reacted to
$NVIDIA (NVDA.US)$
A drop of 6% is like a speck in the daily price movement.
A drop of 6% is like a speck in the daily price movement.
Translated
15
1
もも_2828
liked
The FDA announced Thursday that it has advised COVID-19 vaccine manufacturers to use the KP.2 strain in updated vaccines for the 2024-2025 season.
The FDA advisory committee unanimously decided on 6/5 to recommend the JN.1 strain of the SARS-CoV-2 virus as a vaccine for this season. The committee also discussed recommending the JN.1 strain for the vaccine.
The FDA is currently recommending that KP.2 strain, the so-called flIRT variant, be used in this season's vaccine if possible, based on ongoing monitoring of circulating strains.
Both KP.2 and JN.1 are descendants of the JN.1 lineage.
The FDA says that vaccine supply in the US this year will not be delayed due to this change.
COVID-19 vaccine manufacturers for the US market include Pfizer (NYSE: PFE) /BioNTech (NASDAQ: BNTX), Moderna (NASDAQ: MRNA), and Novavax (NASDAQ: NVAX).
The FDA advisory committee unanimously decided on 6/5 to recommend the JN.1 strain of the SARS-CoV-2 virus as a vaccine for this season. The committee also discussed recommending the JN.1 strain for the vaccine.
The FDA is currently recommending that KP.2 strain, the so-called flIRT variant, be used in this season's vaccine if possible, based on ongoing monitoring of circulating strains.
Both KP.2 and JN.1 are descendants of the JN.1 lineage.
The FDA says that vaccine supply in the US this year will not be delayed due to this change.
COVID-19 vaccine manufacturers for the US market include Pfizer (NYSE: PFE) /BioNTech (NASDAQ: BNTX), Moderna (NASDAQ: MRNA), and Novavax (NASDAQ: NVAX).
Translated
9